Arduini Peter J 4

What Happened
Peter J. Arduini, a director of Bristol Myers Squibb (BMY), was granted 3,996.367 Deferred Share Units on February 1, 2026. The units were recorded at an equivalent value of $55.05 each, totaling $220,000. This transaction is an award/grant (derivative acquisition) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-01; Form 4 filed 2026-02-03 (timely filing).
• Transaction type/code: Award/Grant (A) — 3,996.367 Deferred Share Units at $55.05 per unit; aggregate value $220,000.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes:
  • F1 — Each Deferred Share Unit converts into a share of common stock upon settlement; DSUs become settleable when the reporting person ceases to be a director or at a previously specified future date.
  • F2 — Grant reflects deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Context
Deferred Share Units are a form of deferred compensation that convert into common stock at settlement (often upon leaving the board or at a set future date). Because this is an award under the directors’ deferred compensation plan, it’s not an immediate open‑market purchase or sale and should be viewed as routine compensation rather than a direct market vote by the insider.